Other studies that also analysed biomarkers of general inflammation, including IL-6, indicate that increased concentrations of this parameter in the blood serum of patients are associated with an increased risk of developing BPH and more severe symptoms during its progression [29]. This evidence concerns the gene IL6 and benign prostatic hyperplasia.